BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15920544)

  • 1. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.
    Bhargava R; Gerald WL; Li AR; Pan Q; Lal P; Ladanyi M; Chen B
    Mod Pathol; 2005 Aug; 18(8):1027-33. PubMed ID: 15920544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.
    Li AR; Chitale D; Riely GJ; Pao W; Miller VA; Zakowski MF; Rusch V; Kris MG; Ladanyi M
    J Mol Diagn; 2008 May; 10(3):242-8. PubMed ID: 18403609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.
    Reis-Filho JS; Milanezi F; Carvalho S; Simpson PT; Steele D; Savage K; Lambros MB; Pereira EM; Nesland JM; Lakhani SR; Schmitt FC
    Breast Cancer Res; 2005; 7(6):R1028-35. PubMed ID: 16280056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.
    Sholl LM; John Iafrate A; Chou YP; Wu MT; Goan YG; Su L; Huang YT; Christiani DC; Chirieac LR
    Mod Pathol; 2007 Oct; 20(10):1028-35. PubMed ID: 17673923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients.
    Shawarby MA; Al-Tamimi DM; Ahmed A
    Diagn Pathol; 2011 Jun; 6():57. PubMed ID: 21702909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer.
    Simone G; Mangia A; Malfettone A; Rubini V; Siciliano M; Di Benedetto A; Terrenato I; Novelli F; Mottolese M
    J Exp Clin Cancer Res; 2010 Sep; 29(1):125. PubMed ID: 20843314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.
    Pinter F; Papay J; Almasi A; Sapi Z; Szabo E; Kanya M; Tamasi A; Jori B; Varkondi E; Moldvay J; Szondy K; Keri G; Dominici M; Conte P; Eckhardt S; Kopper L; Schwab R; Petak I
    J Mol Diagn; 2008 Mar; 10(2):160-8. PubMed ID: 18258923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma.
    Soma S; Tsuta K; Takano T; Hatanaka Y; Yoshida A; Suzuki K; Asamura H; Tsuda H
    Pathol Res Pract; 2014 Mar; 210(3):155-60. PubMed ID: 24355440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma.
    Bhargava R; Lal P; Chen B
    Diagn Mol Pathol; 2004 Dec; 13(4):213-6. PubMed ID: 15538111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.
    Gilbert JA; Goetz MP; Reynolds CA; Ingle JN; Giordano KF; Suman VJ; Blair HE; Jenkins RB; Lingle WL; Reinholz MM; Adjei AA; Ames MM
    Mol Cancer Ther; 2008 Apr; 7(4):944-51. PubMed ID: 18413808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome.
    Peiró G; Mayr D; Hillemanns P; Löhrs U; Diebold J
    Mod Pathol; 2004 Mar; 17(3):227-87. PubMed ID: 14752523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast.
    Vranic S; Tawfik O; Palazzo J; Bilalovic N; Eyzaguirre E; Lee LM; Adegboyega P; Hagenkord J; Gatalica Z
    Mod Pathol; 2010 May; 23(5):644-53. PubMed ID: 20208479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study.
    Shia J; Klimstra DS; Li AR; Qin J; Saltz L; Teruya-Feldstein J; Akram M; Chung KY; Yao D; Paty PB; Gerald W; Chen B
    Mod Pathol; 2005 Oct; 18(10):1350-6. PubMed ID: 15832190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression.
    Miyai K; Yamamoto S; Asano T; Tamai S; Matsubara O; Tsuda H
    Cancer Sci; 2010 Sep; 101(9):1970-6. PubMed ID: 20608935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.
    Williams MD; Roberts DB; Kies MS; Mao L; Weber RS; El-Naggar AK
    Clin Cancer Res; 2010 Apr; 16(8):2266-74. PubMed ID: 20371674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.
    Chang JW; Liu HP; Hsieh MH; Fang YF; Hsieh MS; Hsieh JJ; Chiu YT; Tsai HY; Chen YH; Chen YT; Hsu HY; Chen YT; Tsai SF; Chen YR; Hsi BL; Huang SF
    Lung Cancer; 2008 Sep; 61(3):328-39. PubMed ID: 18304690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study.
    Ooi A; Takehana T; Li X; Suzuki S; Kunitomo K; Iino H; Fujii H; Takeda Y; Dobashi Y
    Mod Pathol; 2004 Aug; 17(8):895-904. PubMed ID: 15143334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.